Longitudinal Neoadjuvant and Post- operative Evaluation of Circulating Tumor DNA in Early Breast Cancer using a Tumor-Informed Assay: Updated Analysis of the TRACER Cohort

被引：0
作者：
Elliott, Mitchell
Antras, Jesus Fuentes
Echelard, Philippe
Dou, Aaron
Veitch, Zachary
Bedard, Philippe
Amir, Eitan
Nadler, Michelle
Meti, Nicholas
Gregorio, Nancy
Shah, Elizabeth
Yu, Celeste
Campbell, Nathan
Pipinikas, Christodoulos
Howarth, Karen
Siu, Lillian
Berman, Hal
Cescon, David
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PS06-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS06-08
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
    McDonald, Bradon R.
    Contente-Cuomo, Tania
    Sammut, Stephen-John
    Odenheimer-Bergman, Ahuva
    Ernst, Brenda
    Perdigones, Nieves
    Chin, Suet-Feung
    Farooq, Maria
    Mejia, Rosa
    Cronin, Patricia A.
    Anderson, Karen S.
    Kosiorek, Heidi E.
    Northfelt, Donald W.
    McCullough, Ann E.
    Patel, Bhavika K.
    Weitzel, Jeffrey N.
    Slavin, Thomas P.
    Caldas, Carlos
    Pockaj, Barbara A.
    Murtaza, Muhammed
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (504)
  • [32] Longitudinal evaluation of circulating tumour DNA in early breast cancer using a plasma-only methylation-based assay
    Elliott, M.
    Antras, J. Fuentes
    Dou, A.
    Veitch, Z. W.
    Bedard, P. L.
    Amir, E.
    Nadler, M.
    Van de laar, E.
    Yu, C.
    Annan, M.
    Silvestro, A.
    Zhang, Q.
    Cheikh, R.
    Kim, J.
    Barbash, O.
    Siu, L. L.
    Berman, H.
    Cescon, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S308 - S308
  • [33] Longitudinal analysis of circulating tumor cells and cell free tumor DNA by next generation sequencing in triple negative breast cancer
    Howard, K.
    Austin, S.
    Ramirez, A. B.
    Ritter, L.
    Boles, D.
    Pruitt, J.
    Collins, H.
    Mahen, E.
    Leonti, A.
    Maassel, L.
    Subia, C.
    Tuuli, S.
    Heying, N.
    Deutsch, K.
    Cox, J.
    Lo, F. Y.
    Stilwell, J. L.
    Kaldjian, E. P.
    Dorschner, M.
    Blau, S.
    Blau, A.
    Eisenberg, M.
    Anderson, S.
    Madan, A.
    CANCER RESEARCH, 2016, 76
  • [34] Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer
    Shaw, Jacqui A.
    Brown, James
    Coombes, R. Charles
    Jacob, Jimmy
    Payne, Rachel
    Lee, Belinda
    Page, Karen
    Hava, Natasha
    Stebbing, Justin
    BIOMARKERS IN MEDICINE, 2011, 5 (01) : 87 - 91
  • [35] Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis
    Menghao Dong
    Jian Chen
    Nannan Lu
    Song Wang
    Wenhui Wei
    Ziming Wang
    Jinnan Wang
    Jinguo Zhang
    Xinghua Han
    Fufeng Wang
    Qiuxiang Ou
    Hua Bao
    Xiaopeng Ma
    Benjie Shan
    Yueyin Pan
    Breast Cancer Research, 27 (1)
  • [36] Personalized circulating tumor DNA monitoring to predict response to neoadjuvant therapy in patients with early-stage breast cancer
    George, Mridula
    Meghal, Trishala
    Omene, Coral
    Kalashnikova, Ekaterina
    Fielder, Janie
    Ohri, Nisha
    Kumar, Shicha
    Burkovskaya, Valeria
    Patel, Preena
    Young, Ashley
    Racenstein, Melanie
    Bauman, Tinamarie
    Mchayleh, Wassim
    Toppmeyer, Deborah
    Ganesan, Shridar
    Rosen, Barry
    Rodriguez, Angel
    Liu, Minetta
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery
    Dhiman, Ankit
    Kothary, Vishesh
    Witmer, Hunter D. D.
    Bregio, Celyn
    Sood, Divya
    Ong, Cecilia T.
    Polite, Blase
    Eng, Oliver S.
    Shergill, Ardaman
    Turaga, Kiran K.
    ANNALS OF SURGERY, 2023, 278 (06) : 925 - 931
  • [38] A pooled analysis of multicenter cohort studies of post-surgery circulating tumor DNA (ctDNA) in early stage colorectal cancer (CRC).
    Tie, Jeanne
    Cohen, Joshua
    Wang, Yuxuan
    Li, Lu
    Lee, Margaret
    Wong, Rachel
    Kosmider, Suzanne
    Wong, Hui-Li
    Lee, Belinda
    Burge, Matthew E.
    Yip, Desmond
    Karapetis, Christos Stelios
    Price, Timothy Jay
    Tebbutt, Niall C.
    Haydon, Andrew Mark
    Tomasetti, Cristian
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Importance of circulating tumor DNA analysis at diagnosis in early triple-negative breast cancer patients
    Park, Min-Seung
    Cho, Eun Hye
    Youn, Youngjin
    Do, In-Gu
    Woo, Hee-Yeon
    Park, Hyosoon
    Kim, Eun Young
    Kwon, Min-Jung
    BREAST CANCER, 2025, 32 (02) : 416 - 425
  • [40] Circulating tumor DNA (ctDNA) to predict response to neoadjuvant chemotherapy (NAC) and prognosis in patients (pts) with early breast cancer (BC).
    McHayleh, Wassim
    Young, Ashley
    Burkovskaya, Valeria
    Galuia, Mariem
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345